+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Myasthenia Gravis Treatment Market: Forecast and Trends - Product Thumbnail Image

Myasthenia Gravis Treatment Market: Forecast and Trends

  • Report
  • November 2023
  • 120 Pages
  • Global
From
Liver Cancer Drugs Market 2024-2028 - Product Thumbnail Image

Liver Cancer Drugs Market 2024-2028

  • Report
  • June 2024
  • 142 Pages
  • Global
From
From
From
Integrase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Integrase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Fusion Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Fusion Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • November 2024
  • 224 Pages
  • Global
From
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 181 Pages
  • Global
From
From
Non-Alcoholic Steatohepatitis (NASH) Market 2024-2028 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Market 2024-2028

  • Report
  • August 2024
  • 154 Pages
  • Global
From
Ovulation Inducing Drugs Global Market Report 2024 - Product Thumbnail Image

Ovulation Inducing Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator